1
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Cost-effectiveness of recombinant versus urinary follicle stimulating hormone; whose point of view?

, , , , &
Pages 1141-1142 | Published online: 07 Aug 2009

References

  • Daya S, Gunby J. Recombinant versus urinary FSH for ovarian stimulation in assisted reproduction. Hum Reprod 1999; 14: 2207–15.
  • Ola B, Hammadieh N. A critical appraisal of ‘Recombinant versus urinary FSH for ovarian stimulation in assisted reproduction’ by Daya S and Gunby J. 1999. URL http:// www.thenhs.com/bham-womens/cats/index.
  • Out HJ, Mannaerts BMJL, Driessen SGAJ, Coelingh Bennink HJT. A prospective, randomized, assessor blind, and multicentre study comparing recombinant and urinary follicle stimulating hormones (Puregon versus Metrodin) in in-vitro fertilization Hum Reprod 1995; 10: 2534–40.
  • Human Fertilisation and Embryology Authority (HFEA): Patients’ information and guide. URL. http://www.hfea.gov.uk/frame2.htm.
  • Greenhalgh T. How to read a paper: Papers that tell you what things cost (economic analyses). BMJ 1997; 315: 596–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.